» Articles » PMID: 4633984

Imaging of Bone Metastases with 99m Tc-Sn-EHDP (diphosphonate), 18 F, and Skeletal Radiography. A Comparison of Sensitivity

Overview
Journal Radiology
Specialty Radiology
Date 1973 Jun 1
PMID 4633984
Citations 16
Authors
Affiliations
Soon will be listed here.
Citing Articles

Nuclear medicine imaging for bone metastases assessment: what else besides bone scintigraphy in the era of personalized medicine?.

Ouvrard E, Kaseb A, Poterszman N, Porot C, Somme F, Imperiale A Front Med (Lausanne). 2024; 10:1320574.

PMID: 38288299 PMC: 10823373. DOI: 10.3389/fmed.2023.1320574.


Nuclear medicine and multimodality imaging of pediatric neuroblastoma.

Mueller W, Coppenrath E, Pfluger T Pediatr Radiol. 2012; 43(4):418-27.

PMID: 23151727 DOI: 10.1007/s00247-012-2512-1.


¹⁸F-Fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy.

Bortot D, Amorim B, Oki G, Gapski S, Santos A, Lima M Eur J Nucl Med Mol Imaging. 2012; 39(11):1730-6.

PMID: 22949079 DOI: 10.1007/s00259-012-2195-8.


Nuclear medicine: radionuclide imaging in metastatic and metabolic bone disease.

Krishamurthy G, Blahd W West J Med. 1977; 126(6):488.

PMID: 18747958 PMC: 1237642.


Increased Sensitivity of 99mTc-Diphosphonate Over Radiography in Skeletal Imaging for Metastases.

Morton M West J Med. 1974; 120(2):147-8.

PMID: 18747325 PMC: 1129353.